Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A
3(100.0%)
3Total
N/A(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT05000593Not ApplicableCompleted

Clinical Study of Cord Blood Mononuclear Cells (UCB-MNCs) in the Treatment of Knee Osteoarthritis

Role: lead

NCT05024526Not ApplicableUnknown

Protective Effects of Edaravone Dexborneol

Role: lead

NCT05003869Not ApplicableUnknown

Clinical and Basic Research on the Necessity of Scar Tissue Resection During Intrauterine Adhesions

Role: lead

NCT04996953Unknown

The Correlation Study of Hypnotic Drugs on the Cognitive Function of Patients With Chronic Insomnia.

Role: lead

All 4 trials loaded